ADiTx Therapeutics logo
ADiTx Therapeutics ADTX
report update icon

Quarterly report 2026-Q1
added 11-21-2026

ADiTx Therapeutics Market Cap | ADTX

As of November 22, 2026 ADiTx Therapeutics has a market cap of $ 374


Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]

Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.

This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.

Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.

Annual Market Cap ADiTx Therapeutics

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
36.6 K 8.98 M 2.94 K 42.7 K 141 K 25.7 M - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
25.7 M 2.94 K 5.82 M

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.

Market Cap of other stocks in the Biotechnology industry

Issuer Market Cap Price % 24h Market Cap Country
Auris Medical Holding Ltd. Auris Medical Holding Ltd.
EARS
8.29 M - -1.77 % $ 39.2 M bermudaBermuda
Dicerna Pharmaceuticals, Inc. Dicerna Pharmaceuticals, Inc.
DRNA
1.67 B - 0.34 % $ 2.98 B usaUSA
ERYTECH Pharma S.A. ERYTECH Pharma S.A.
ERYP
24.2 M - 1.3 % $ 27.7 M franceFrance
GW Pharmaceuticals plc GW Pharmaceuticals plc
GWPH
4.79 B - - $ 6.81 B britainBritain
22nd Century Group 22nd Century Group
XXII
541 K $ 0.32 -19.83 % $ 58.9 K usaUSA
Kadmon Holdings, Inc. Kadmon Holdings, Inc.
KDMN
813 M - - $ 1.7 B usaUSA
Liminal BioSciences Liminal BioSciences
LMNL
2.65 M - - $ 256 M canadaCanada
argenx SE argenx SE
ARGX
42.4 B $ 926.42 -1.66 % $ 56.8 B niderlandNiderland
Tonix Pharmaceuticals Holding Corp. Tonix Pharmaceuticals Holding Corp.
TNXP
114 M $ 2.33 -7.25 % $ 19.8 M usaUSA
Zai Lab Limited Zai Lab Limited
ZLAB
21.6 B $ 21.01 -4.16 % $ 23 B chinaChina
Neos Therapeutics, Inc. Neos Therapeutics, Inc.
NEOS
80.6 M - -2.54 % $ 57.2 M usaUSA
Zentalis Pharmaceuticals Zentalis Pharmaceuticals
ZNTL
192 M $ 1.37 0.74 % $ 98.5 M usaUSA
Zoetis Zoetis
ZTS
56.1 B $ 78.81 -2.47 % $ 34.9 B usaUSA
Odonate Therapeutics, Inc. Odonate Therapeutics, Inc.
ODT
759 M - -3.18 % $ 58.5 M usaUSA
Orphazyme A/S Orphazyme A/S
ORPH
236 M - -2.25 % $ 31.3 M danmarkDanmark
Osmotica Pharmaceuticals plc Osmotica Pharmaceuticals plc
OSMT
262 M - -10.74 % $ 89.9 M usaUSA
Pandion Therapeutics, Inc. Pandion Therapeutics, Inc.
PAND
419 M - - $ 1.77 B usaUSA
Xenetic Biosciences Xenetic Biosciences
XBIO
4.37 M $ 1.47 -4.55 % $ 2.5 M usaUSA
Translate Bio, Inc. Translate Bio, Inc.
TBIO
1.23 B - - $ 2.81 B usaUSA
Trillium Therapeutics Inc. Trillium Therapeutics Inc.
TRIL
1.1 B - - $ 1.94 B canadaCanada
Urovant Sciences Ltd. Urovant Sciences Ltd.
UROV
273 B - - $ 532 M britainBritain
Acceleron Pharma Inc. Acceleron Pharma Inc.
XLRN
6.89 B - - $ 10.9 B usaUSA
Zogenix, Inc. Zogenix, Inc.
ZGNX
1.02 B - -4.97 % $ 664 M usaUSA
Yunhong International Yunhong International
ZGYH
18.2 M - 0.10 % $ 92.2 M chinaChina
ZIOPHARM Oncology, Inc. ZIOPHARM Oncology, Inc.
ZIOP
790 M - -7.58 % $ 264 M usaUSA
Taysha Gene Therapies Taysha Gene Therapies
TSHA
1.46 B $ 3.71 -1.72 % $ 1.19 B usaUSA
Vericel Corporation Vericel Corporation
VCEL
1.88 B $ 57.41 -1.46 % $ 2.89 B usaUSA
Vir Biotechnology Vir Biotechnology
VIR
1.02 B $ 8.37 -5.64 % $ 1.16 B usaUSA
Veracyte Veracyte
VCYT
3.04 B $ 25.08 0.16 % $ 1.97 B usaUSA
Viking Therapeutics Viking Therapeutics
VKTX
3.18 B $ 24.72 -4.35 % $ 2.79 B usaUSA
Vanda Pharmaceuticals Vanda Pharmaceuticals
VNDA
358 M $ 3.44 -6.27 % $ 203 M usaUSA
VistaGen Therapeutics VistaGen Therapeutics
VTGN
21.7 M $ 0.16 -12.33 % $ 6.09 M usaUSA
Voyager Therapeutics Voyager Therapeutics
VYGR
241 M $ 1.52 -5.9 % $ 89.2 M usaUSA
Verrica Pharmaceuticals Verrica Pharmaceuticals
VRCA
66.7 M $ 2.74 -5.03 % $ 29.2 M usaUSA
Wave Life Sciences Ltd. Wave Life Sciences Ltd.
WVE
2.6 B $ 2.56 -6.07 % $ 432 M singaporeSingapore
XBiotech XBiotech
XBIT
70.4 M $ 1.75 4.17 % $ 53.4 M usaUSA
XTL Biopharmaceuticals Ltd. XTL Biopharmaceuticals Ltd.
XTLB
855 M $ 1.37 -7.43 % $ 922 M israelIsrael
Adial Pharmaceuticals Adial Pharmaceuticals
ADIL
1.31 M $ 3.15 -35.42 % $ 2.11 M usaUSA
ADMA Biologics ADMA Biologics
ADMA
3.78 B $ 13.18 -1.2 % $ 3.14 B usaUSA
Exicure Exicure
XCUR
29 M $ 0.96 -7.24 % $ 6.05 M usaUSA
Xencor Xencor
XNCR
892 M $ 33.48 -1.56 % $ 2.49 B usaUSA
Cortexyme Cortexyme
CRTX
70 M - -1.05 % $ 67.1 M usaUSA
Burford Capital Limited Burford Capital Limited
BUR
2.78 B $ 3.24 -5.55 % $ 710 M britainBritain
Daré Bioscience Daré Bioscience
DARE
16.9 M $ 0.41 -9.93 % $ 4.58 M usaUSA
Fate Therapeutics Fate Therapeutics
FATE
187 M $ 0.92 -9.07 % $ 109 M usaUSA
Greenwich LifeSciences Greenwich LifeSciences
GLSI
386 M $ 19.09 -3.54 % $ 258 M usaUSA
Halozyme Therapeutics Halozyme Therapeutics
HALO
9.66 B $ 91.28 -1.89 % $ 10.9 B usaUSA
Hutchison China MediTech Limited Hutchison China MediTech Limited
HCM
12 B $ 13.18 -2.04 % $ 11.3 B chinaChina
Aptorum Group Limited Aptorum Group Limited
APM
6.69 M - - $ 5.72 M chinaChina
iBio iBio
IBIO
142 M $ 0.83 3.01 % $ 86.4 M usaUSA